After presentation of the SHAPE trial at ASCO, would you consider offering a simple hysterectomy with pelvic LN dissection for early stage cervical cancer <2cm?   

If yes, would you consider a minimally invasive approach despite the LACC trial results?

If no, what additional research/information is needed to change your practice? 



Answer from: at Academic Institution